Essa Pharma Inc [EPIX] stock prices are up 8.77% to $1.86 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The EPIX shares have gain 9.41% over the last week, with a monthly amount glided 10.06%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Essa Pharma Inc [NASDAQ: EPIX] stock has seen the most recent analyst activity on November 04, 2024, when Piper Sandler downgraded its rating to a Neutral and also revised its price target to $2 from $15. Previously, Oppenheimer downgraded its rating to Perform on November 04, 2024. On November 04, 2024, downgrade downgraded it’s rating to Hold. Piper Sandler initiated its recommendation with a Overweight and recommended $50 as its price target on March 04, 2021. H.C. Wainwright reiterated a Buy rating for this stock on January 11, 2021, and upped its price target to $17. In a note dated November 02, 2020, Jefferies initiated an Buy rating and provided a target price of $17 on this stock.
The stock price of Essa Pharma Inc [EPIX] has been fluctuating between $1.40 and $7.88 over the past year. Currently, Wall Street analysts expect the stock to reach $9.5 within the next 12 months. Essa Pharma Inc [NASDAQ: EPIX] shares were valued at $1.86 at the most recent close of the market. An investor can expect a potential return of 410.75% based on the average EPIX price forecast.
Analyzing the EPIX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.19, Equity is -0.18 and Total Capital is -0.18.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.8467 points at the first support level, and at 1.8333 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.8767, and for the 2nd resistance point, it is at 1.8933.
Ratios To Look Out For
It’s worth pointing out that Essa Pharma Inc [NASDAQ:EPIX]’s Current Ratio is 67.17. On the other hand, the Quick Ratio is 67.17.
Transactions by insiders
Recent insider trading involved BIOTECH GROWTH N V, 10% Owner, that happened on Nov 01 ’24 when 7.88 million shares were sold. Chief Operating Officer, Virsik Peter completed a deal on Oct 07 ’24 to sell 694.0 shares. Meanwhile, Chief Operating Officer Virsik Peter sold 694.0 shares on Sep 09 ’24.
